Dr. Adam
Friedman
Scientific Advisor
Professor and Chair of Dermatology, Residency Program Director of Translational Research, and Director of Supportive Oncodermatology at George Washington University
Dr. Friedman holds multiple titles at the George Washington University School of Medicine and Health Sciences. He is Professor and Chair of Dermatology, Residency Program Director of Translational Research, and Director of Supportive Oncodermatology. After attending medical school at the Albert Einstein College of Medicine, Dr. Friedman completed his internship at the New York Hospital of Queens before returning to Albert Einstein to complete his residency in Dermatology, where he also stayed on as faculty for five years.
Dr. Friedman has diverse research interests, with foci ranging from nanotechnology applications in dermatology to teaching and clinical gaps identification. He also specializes in the use of cannabinoids to potentially treat inflammatory dermatological conditions. Dr. Friedman’s work has resulted in multiple patents and over 230 peer-reviewed articles. He has received several accolades, including the Cutting Edge Research Award from the American Society for Dermatology Society and the Young Leader Award from the American Dermatologic Association. Dr. Friedman is the President of the Derma Care Access Network, Chair of the AAD Annual Meeting Poster Task Force, Senior Editor for Dermatology In-Review, and Co-Chair of the ODAC Conference.
